Aclaris is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of immuno-inflammatory diseases.
$80M
Nov 18, 2024
-
Garuda is a Massachusetts-based biotechnology company that researches and develops blood stem cell therapies for the treatment of life-threatening diseases for individuals.
$47.7M
Oct 16, 2024
-
Treeline Biosciences is a Connecticut-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer.
$421.8M
Oct 01, 2024
-
Bicara is a Massachusetts-based biotechnology company that researches and develops bifunctional antibody therapies for the treatment of cancer.
$165M
Dec 11, 2023
-
COMPASS Pathways is an England-based pharmaceutical firm that researches and develops psilocybin therapy for the treatment of mental health disorders for patients.
$285M
Aug 17, 2023
-
Frequently Asked Questions about Aisling Capital
What is Aisling Capital investing in?
Aisling Capital has invested in 90 companies including Aclaris, Garuda Therapeutics and Treeline Biosciences
What company did Aisling Capital invest in?
Aisling Capital invested in a total 90 companies including Aclaris, Garuda Therapeutics and Treeline Biosciences
What are the top 5 investments by Aisling Capital?
The top companies in which Aisling Capital invested are Aclaris, Garuda Therapeutics, Treeline Biosciences, Bicara and COMPASS Pathways
